Scientists test One-Two punch against tough leukemia

This early-stage study is testing whether it's safe and practical to give a pill called dasatinib alongside a specialized cell therapy (Tecartus) for adults whose acute lymphoblastic leukemia has returned or hasn't responded to other treatments. The main goal is to see if patients can take the dasatinib pills as scheduled during the first month after receiving the cell therapy. Researchers will also check if the combination helps control the cancer and for how long.